For: | Baumert JT, Sparmann G, Emmrich J, Liebe S, Jaster R. Inhibitory effects of interferons on pancreatic stellate cell activation. World J Gastroenterol 2006; 12(6): 896-901 [PMID: 16521217 DOI: 10.3748/wjg.v12.i6.896] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i6/896.htm |
Number | Citing Articles |
1 |
Soumya Jagannath, Pramod Kumar Garg. Novel and Experimental Therapies in Chronic Pancreatitis. Digestive Diseases and Sciences 2017; 62(7): 1751 doi: 10.1007/s10620-017-4604-0
|
2 |
Rupjyoti Talukdar, Rakesh K Tandon. Pancreatic stellate cells: New target in the treatment of chronic pancreatitis. Journal of Gastroenterology and Hepatology 2008; 23(1): 34 doi: 10.1111/j.1440-1746.2007.05206.x
|
3 |
Atsushi Masamune, Tooru Shimosegawa. Signal transduction in pancreatic stellate cells. Journal of Gastroenterology 2009; 44(4): 249 doi: 10.1007/s00535-009-0013-2
|
4 |
Brit Fitzner, Stephanie-Anna Holzhueter, Saleh Ibrahim, Horst Nizze, Robert Jaster. Interferon-Gamma Treatment Accelerates and Aggravates Autoimmune Pancreatitis in the MRL/Mp-Mouse. Pancreatology 2009; 9(3): 233 doi: 10.1159/000199434
|
5 |
Jaganmay Sarkar, Hiranmoy Das. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 3987 doi: 10.1007/978-981-16-5422-0_272
|
6 |
Robin Bülow, Brit Fitzner, Gisela Sparmann, Jörg Emmrich, Stefan Liebe, Robert Jaster. Antifibrogenic effects of histone deacetylase inhibitors on pancreatic stellate cells. Biochemical Pharmacology 2007; 74(12): 1747 doi: 10.1016/j.bcp.2007.08.023
|
7 |
Divya Thomas, Prakash Radhakrishnan. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1234: 57 doi: 10.1007/978-3-030-37184-5_5
|
8 |
Falko Lange, Katja Rateitschak, Brit Fitzner, Ralf Pöhland, Olaf Wolkenhauer, Robert Jaster. Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach. Molecular Cancer 2011; 10(1) doi: 10.1186/1476-4598-10-13
|
9 |
Katja Rateitschak, Felix Winter, Falko Lange, Robert Jaster, Olaf Wolkenhauer, Scott Markel. Parameter Identifiability and Sensitivity Analysis Predict Targets for Enhancement of STAT1 Activity in Pancreatic Cancer and Stellate Cells. PLoS Computational Biology 2012; 8(12): e1002815 doi: 10.1371/journal.pcbi.1002815
|
10 |
Anika Jonitz, Brit Fitzner, Robert Jaster. Molecular determinants of the profibrogenic effects of endothelin-1 in pancreatic stellate cells. World Journal of Gastroenterology 2009; 15(33): 4143-4149 doi: 10.3748/wjg.15.4143
|
11 |
Lennard Spanehl, Denis Revskij, Karen Bannert, Luise Ehlers, Robert Jaster. YAP activates pancreatic stellate cells and enhances pancreatic fibrosis. Hepatobiliary & Pancreatic Diseases International 2022; 21(6): 583 doi: 10.1016/j.hbpd.2022.06.004
|
12 |
Voddu Suresh, Pujarini Dash, Sujit Suklabaidya, Krushna Chandra Murmu, Prakash K. Sasmal, Gajendra M. Jogdand, Deepti Parida, Manisha Sethi, Biswajit Das, Debasish Mohapatra, Subha Saha, Punit Prasad, Abhay Satoskar, Shantibhusan Senapati.
MIF
confers survival advantage to pancreatic
CAFs
by suppressing interferon pathway‐induced p53‐dependent apoptosis
. The FASEB Journal 2022; 36(8) doi: 10.1096/fj.202101953R
|
13 |
Andrew Cannon, Christopher Michael Thompson, Rakesh Bhatia, Katharine Anne Armstrong, Joyce Christopher Solheim, Sushil Kumar, Surinder Kumar Batra. Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma. Journal of Gastroenterology 2021; 56(8): 689 doi: 10.1007/s00535-021-01800-4
|
14 |
Siri Dunér, Jacob Lopatko Lindman, Daniel Ansari, Chinmay Gundewar, Roland Andersson. Pancreatic Cancer: The Role of Pancreatic Stellate Cells in Tumor Progression. Pancreatology 2011; 10(6): 673 doi: 10.1159/000320711
|
15 |
Daniel Ansari, Ellen Andersson, Bodil Andersson, Roland Andersson. Chronic pancreatitis: potential future interventions. Scandinavian Journal of Gastroenterology 2010; 45(9): 1022 doi: 10.3109/00365521003734174
|
16 |
Despina Bazou, Nir Maimon, Lance Munn, Iciar Gonzalez. Effects of Low Intensity Continuous Ultrasound (LICU) on Mouse Pancreatic Tumor Explants. Applied Sciences 2017; 7(12): 1275 doi: 10.3390/app7121275
|
17 |
S. Bolivar, J.A. Espitia-Corredor, F. Olivares-Silva, P. Valenzuela, C. Humeres, R. Anfossi, E. Castro, R. Vivar, A. Salas-Hernández, V. Pardo-Jiménez, G. Díaz-Araya. In cardiac fibroblasts, interferon-beta attenuates differentiation, collagen synthesis, and TGF-β1-induced collagen gel contraction. Cytokine 2021; 138: 155359 doi: 10.1016/j.cyto.2020.155359
|
18 |
Morgan K. Groover, Jillian M. Richmond. Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases. F1000Research 2020; 9: 1197 doi: 10.12688/f1000research.26728.1
|
19 |
Ratnakar R Bynigeri, Aparna Jakkampudi, Ramaiah Jangala, Chivukula Subramanyam, Mitnala Sasikala, G Venkat Rao, D Nageshwar Reddy, Rupjyoti Talukdar. Pancreatic stellate cell: Pandora's box for pancreatic disease biology. World Journal of Gastroenterology 2017; 23(3): 382-405 doi: 10.3748/wjg.v23.i3.382
|
20 |
Robert Jaster, Jörg Emmrich. Crucial role of fibrogenesis in pancreatic diseases. Best Practice & Research Clinical Gastroenterology 2008; 22(1): 17 doi: 10.1016/j.bpg.2007.10.004
|
21 |
Katja Rateitschak, Anna Karger, Brit Fitzner, Falko Lange, Olaf Wolkenhauer, Robert Jaster. Mathematical modelling of interferon-γ signalling in pancreatic stellate cells reflects and predicts the dynamics of STAT1 pathway activity. Cellular Signalling 2010; 22(1): 97 doi: 10.1016/j.cellsig.2009.09.019
|
22 |
Jaganmay Sarkar, Hiranmoy Das. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1 doi: 10.1007/978-981-16-1247-3_272-1
|
23 |
Brit Fitzner, Peter Brock, Hana Nechutova, Änne Glass, Thomas Karopka, Dirk Koczan, Hans-Jürgen Thiesen, Gisela Sparmann, Jörg Emmrich, Stefan Liebe, Robert Jaster. Inhibitory effects of interferon-γ on activation of rat pancreatic stellate cells are mediated by STAT1 and involve down-regulation of CTGF expression. Cellular Signalling 2007; 19(4): 782 doi: 10.1016/j.cellsig.2006.10.002
|